In the fission yeast Schizosaccharomyces pombe, rasl regulates both sexual development (conjugation and sporulation) and cellular morphology. Two types of dominant interfering mutants were isolated in a genetic screen for rasi mutants that blocked sexual development. The first type of mutation, at Ser-22, analogous to the H-rasAsnl7 mutant (L. A. Feig and G. M. Cooper, Mol. Cell. Biol. 8:3235-3243, 1988 ), blocked only conjugation, whereas a second type of mutation, at Asp-62, interfered with conjugation, sporulation, and cellular morphology. Analogous mutations at position 64 of Saccharomyces cerevisiae RAS2 or position 57 of human H-ras also resulted in dominant interfering mutants that interfered specifically and more profoundly than mutants of the first type with RAS-associated pathways in both S. pombe or S. cerevisiae. Genetic evidence indicating that both types of interfering mutants function upstream of RAS is provided. Biochemical evidence showing that the mutants are altered in their interaction with the CDC25 class of exchange factors is presented.
We show that both H-rasAn'17 and H-rasTyr5s7, compared with wild-type H-ras, are defective in their guanine nucleotide-dependent release from human cdc25 and that this defect is more severe for the H-ras Tyr-57 mutant. Such a defect would allow the interfering mutants to remain bound to, thereby sequestering RAS exchange factors. The more severe interference phenotype of this novel interfering mutant suggests that it functions by titrating out other positive regulators of RAS besides those encoded by ste6 and CDC25. Mutant versions of RAS proteins are found in a wide variety of human tumors (3) . The normal vertebrate RAS regulates cellular growth, morphology, and differentiation (4) . In the yeast Saccharomyces cerevisiae, RAS is required for vegetative growth (5, 46) . In the yeast Schizosaccharomyces pombe, RAS is involved in pathways controlling sexual differentiation and cellular morphology (19, 40, 41) . In each of these diverged species, it is evident that the nucleotide-bound state of RAS proteins regulates its activity. The conversion of the inactive RAS -GDP to the active RAS -GTP is regulated by guanine nucleotide exchange factors (GEFs) structurally and functionally related to the yeast S. cerevisiae CDC25 gene product (13) .
Previously, RAS mutants which dominantly interfere with wild-type RAS functions in the yeast S. cerevisiae and in animal cells, namely, H-rasA"al5 or its yeast homolog RAS2Aa- 22 (48) and H-rasA'"17 (15) , have been identified. The H-rasAlal5 and RAS2AIa-22 mutants likely act by titrating out upstream RAS GEFs. Evidence for this comes from the observation that the dominant interference of either mutant expressed in S. cerevisiae can be suppressed by overexpression of the RAS-GEF encoded by CDC25 (45) . Furthermore, in a two-hybrid assay, yeast CDC25 was found to bind the RAS2Ala-22 mutant more strongly than wild-type RAS2 (38) . The mechanism by which dominant interfering mutants titrate out GEFs remains unclear, but there is evidence to suggest that the interfering mutants are locked into an inactive conformation that binds to and sequesters the intracellular pool of GEFs (14, 28, 38) .
The goal of our current study was to probe the function of RAS in the fission yeast S. pombe by generating dominant interfering RAS mutants. The RAS pathways in S. pombe are not mediated by adenylyl cyclase as they are in S. cerevisiae (5, 56) . The organism S. pombe has a single RAS homolog, rasl (19, 41) , that is not involved in vegetative growth but rather is required for sexual differentiation and cellular morphology (40) . A positive regulator of rasl, encoded by ste6 (26) , is structurally and functionally related to the S. cerevisiae RAS-GEF encoded by CDC25. In S. pombe, two signals, nutrient starvation and pheromones, lead to conjugation between the two mating types h+ and h-. The conjugated cells then sporulate to form zygotic asci. raslnuI cells are viable but defective in sporulation and conjugation; such cells also are rounded, whereas wild-type cells exhibit an elongated morphology (20, 40) . In contrast to raslnuI cells, ste6null cells are defective in conjugation but are normal with respect to both sporulation and cellular morphology. Disruption of the rasl gene, therefore, has a more pronounced effect than disruption of this upstream activator. The search for interfering mutants of rasl in S. pombe is attractive since rasl is not an essential gene and its protein product potentially regulates more than one pathway, as suggested by its roles in both sexual differentiation and cellular morphology. Here we describe the characterization of a novel dominant interfering mutant of S. pombe rasl containing substitutions at Asp-62. We have made analogous mutants of S. cerevisiae RAS2 and vertebrate H-ras and have characterized their interfering properties as well.
MATERIALS AND METHODS
Plasmids, yeast strains, and reagents. All strains and plasmids used in this study are described in Tables 1 and 2. 3708 JUNG ET AL. MA4Ta his3 leu2 ura3 trp] ade8 can] rasl::URA3 ras2ts 48 
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MATa his3 leu2 ura3 trpl ad8 can] RAS2Val- 19 56 Plasmid pAAUN-rasl, expressing a cDNA for S. pombe rasi, SPraslTYr-62, respectively, were generated by transforming S. was obtained from Hao-Peng Xu. Plasmid pART3-ste6, ex-pombe SP66 with a NotI fragment derived from plasmids pressing the exchange factor for Rasl, and plasmid pUC-ral2, pVINCE1-SPraslC22 and pVIN1-SPraslY62 (see below), recontaining the genomic clone of ral2, a putative upstream spectively. S. cerevisiae RB5 was constructed by mating a regulator of Rasl in S. pombe (21) , were the kind gifts of M. cdc25nuIl strain to an iralnull ira2null strain, sporulating, and Yamamoto. Plasmid pART1-ral2, expressing the cDNA of the selecting for complementation of auxotrophic markers. ral2 gene, was obtained by PCR using plasmid pUC-ral2 as the Construction of mutant S. pombe rasi library. Mutagenesis template and two primers containing internal BamHI sites (in of S. pombe rasl was carried out by PCR as described by Zhou boldface) to facilitate cloning into plasmid pART1: 5'-CT et al. (66) . The following 5' and 3' oligonucleotide primers TA1TAACGTCGGGATCCTAAACAGT-3' and 5'-GATA were used: 5'-C'TTIAGTGTGCTY1ATAGGATCCTGAA-3' GAGCTACGGAGGATCCAAATGCA-3'. and 5'-GATCGGTGCATTCACCAAAGAGCTCA-3'. These S. pombe SP66-R1C22 and SP66-R1Y62, containing the oligonucleotides contain, respectively, BamHI and SstI sites (in integrated dominant interfering mutants SPraslCYs22 and boldface) for directional cloning into identical sites in the S. FIG. 1. Plasmids pVlNl and pVINCEI were constructed as described in the text. All sites except for Xbal are unique in the polylinker. These vectors contain the S. cerevisiae ADE2 gene, a polylinker, or an S. pombe adh promoter flanked by S. pombe ura4 segments. The entire insert can be removed by Notl digestion for transformation into S. pombe. Integration into the ura4 locus can be verified by complementation of the adenine auxotrophy and loss of uracil prototrophy. pombe expression vector pART1 (35) . A library of over 107 clones was generated from a pool of eight separate 50-,ul PCRs.
Selection of S. pombe rasi dominant interfering mutants.
DNA from the mutant S. pombe rasl library was isolated and transformed by the lithium acetate method (27) into wild-type S. pombeSP870. Cells were plated such that approximately 200 to 300 transformants grew per selective plate. Colonies defective for conjugation or sporulation were detected by the iodine vapor staining method (32) . Plasmid DNA was isolated from these cells and retransformed into wild-type cells to confirm that the interference was due to the presence of the plasmid. (33, 42) . After cloning of the desired cDNA into the polylinker, the integrating fragment can be excised by NotI digestion for transformation. Successful disruption of the ura4 locus can be identified by growth in adenine-free plates and failure to grow in uracil-free plates. pVIN1 (vector for integration; Fig. 1 ) is similar to pVINCE1 except that it was designed for integration of cloned genomic fragments. This plasmid was constructed by a partial BglII digestion of pVINCE1 followed by PstI digestion to remove the adh promoter, then blunt ended by T4 polymerase, and self-religated.
The dominant interfering SPraslCys22 and SPraslTYr62 mutants were cloned into pVINCE-1, using restriction enzyme sites BamHI and SstI to create plasmids pVINCE1-SPraslC22 and pVINCE1-SPraslY62, respectively.
Site-specific mutagenesis of RAS genes and cloning into expression vectors. Site-directed mutagenesis by the doubleprimer method (12) was used to modify RAS genes (Transformer mutagenesis kit; Clontech, Palo Alto, Calif.). Primer 5'-TGGACAThTTGTATACGGCAGGGCAGGAAG-3' was used to change residue 64 of S. cerevisiae RAS2, cloned into plasmid YEplacll2 (23) , from an aspartic acid to a tyrosine, to create plasmid YEplacll2-R2Y64. Amino acid residue 57 of human H-ras in plasmid pAAU-HR (59) was changed from an aspartic acid to tyrosine, using the oligonucleotide 5'-CTGGC CGGCGGTATACAGGATGTCCAA-3' to create plasmid pAAU-HRY57. Position 35 of the effector loop (52, 64) in wild-type H-ras (H-ras'W) and H-rasTYr-57 was changed from a threonine to an alanine by mutagenesis of plasmids pVINCE1-HR and pVINCE1-HRY57 by using the oligonucleotide 5'-ACGAATACGACCCCGCTATAGAGGATTC-3', thereby creating plasmids pVINCE1-HRA35 and pVINCE1-HRA35Y57, respectively.
Plasmid pAL-SPraslY62 contains the genomic rasl gene with a Tyr-62 mutation and was constructed by exchanging a BsaBI-SstI fragment of rasl from pART1-SPraslY62 into plasmid pALR (59) containing a genomic clone of rasl. The genomic clone of SPraslTYr,62 was then transferred into vector pVIN1 to generate plasmid pVIN1-SPraslY62.
R4S2TY'`was amplified by PCR from plasmid YEplacll2-R2Y64 by using two oligonucleotides, 5'-GAAAGGAGATATA CAGAGTCGACAATGCCT-3' and 5'-GTGAAAATGGATGT GAITTGTCGACTCTCICG-3', that contain intemal Sall sites (in boldface) for insertion into yeast expression vectors pAD4A or pAD54 (2, 17) to generate plasmids pAD4A-R2Y64 and pAD54-R2Y64, respectively. Plasmid pAD4A-R2A22 was generated similarly, using as the template the genomic clone of the RAS2""-77
allele (48) . The HinsTyr mutant gene was excised as a BamHI-SstI fragment from plasmid pAAU-HRY57 and cloned into vectors pART1 and pVINCE1, to generate pART1-HRY57 and pVINCE1-HRY57, respectively, or as a SalI-SstI fragment for cloning into pAD4A to generate plasmid pAD4A-HRY57.
Cys-186 of the CAAX processing motif (62,63) of H-ras>57 was changed to a serine by PCR-directed mutagenesis using oligonucle-VOL. 14, 1994 3710 JUNG ET AL. otides 5'-CCTCAGGATCCGAATGACGGAATATAAGCT-3' and 5'-CCATGGTCGACTCAGGAGAGCACACT(C1-3'. The BamHI and Sal sites (in boldface) allowed for cloning into identical sites in vector pARTl to create pART1-HRY57S186. The complement of ACT (underlined) encodes the serine mutation.
Conjugation and sporulation frequencies for S. pombe. After cells were transformed, the colonies were grown and starved for 1 week. Haploid cells of opposite mating types will conjugate to form zygotic asci that can be easily distinguished by their boomerang morphology, the angle representing their point of conjugation (see Fig. 2 and Results). In the case of cells that are conjugation defective, diploids can be generated by cell fusion. The sporulation of these diploidized cells generates azygotic asci (see Fig. 2D ). The frequencies of zygotic or azygotic ascus formation, determined by microscopic observation, were used to calculate, respectively, the conjugation and sporulation efficiencies.
Heat shock assays for S. cerevisiae. The heat shock assays (50, 56) were performed by replica plating patches of cells that had been starved for 2 to 3 days onto plates that were preheated for 1 h at 52 or 55°C, incubated for 2.5, 5, and 10 min at the indicated temperature, and then transferred to 30°C for 2 to 3 days. Two-hybrid system for studies of RAS interactions. We used the modified two-hybrid system developed by S. M. Hollenberg, H. R.
Stemglanz, and H. Weintraub as described by Vojtek et al. (58) to analyze interactions of RAS with its effectors. Reporter S. cerevisiae strain LAO0 and plasmids pLexA-Rasyr, pLexA-Rasvl2, pLexA_ RaSA15, pVPl6, pVPl6-CYR, and pVPl6-RAF were the generous gifts of Anne Vojtek. The gene encoding H-rasTYS7 was amplified by PCR using the two oligonucleotides 5'-CCTCAGGATCCGA ATGACGGAATATAAGCT-3' and 5'-CCATGGTCGACTCAG GAGAGCACACAC1T-3'. These oligonucleotides contain intemal BamHI and Sail sites (in boldface), respectively, to permit cloning into vector pBTM116 (58), creating pLexA-HRY57.
Purification of H-ras proteins and guanine nucleotide binding. H-ras' and dominant interfering H-rasTYr-57 were cloned into the pTrcHis Xpress System (Invitrogen, San Diego, Calif.) vectors for expression of His6-tagged proteins and transformed into Escherichia coli DH1OB (Bethesda Research Laboratories, Gaithersburg, Md.). Protein was purified as described by the manufacturers except that 1 mM MgCl2 was included in all buffer conditions. The supernatant was passed through Ni2+charged Sepharose ProBond resin (Invitrogen) and eluted by using step gradients of lysis buffer containing 40, 60, 100, 200, 500, and 1,000 mM imidazole. The H-ras proteins eluted at 200 mM imidazole at greater than 90% purity, as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. The proteins were concentrated by Centricon (Amicon, Lexington, Mass.) centrifugation, adjusted to 40% glycerol, and stored at -20°C. Nucleotide-free H-ras proteins were prepared essentially as described by Crechet et al. (11) except that after EDTA treatment, buffer was exchanged by Centricon centrifugation. Relative affinities for nucleotides were determined as described by Farnsworth and Feig (14) by incubating 5 pmol of purified nucleotide-free H-ras proteins in 100 pI of binding buffer containing 0.5 ,uM [3H]GDP and various concentrations of unlabeled GDP or GTP as described for Fig. 5 . Bound counts were determined by a nitrocellulose filter assay (16) .
Interaction of H-ras proteins with the catalytic domain of the human cdc25GEF. A plasmid designed to expressed glutathione S-transferase (GST) fused to a human RAS guanine nucleotide exchange factor, cdc25GEF (60) , was made by cloning of codons 863 to 1275 of cdc25GEF into vector pGEX-2T (Pharmacia, Piscataway, N.J.). Induction and bind-ing of the GST-cdc25GEF to glutathione-agarose were performed as described previously (31) . Plasmids for expression of His6-tagged H-rasWT and H-rasTYr-57 proteins are described above. The H-rasAsni17 expression plasmid, pAT-rasH(17N), was kindly provided by C. Der. E. coli cells containing each of the H-ras expression plasmids were grown to an optical density at 600 nm of 0.4. Isopropylthiogalactopyranoside (IPTG) was added to a final concentration of 1 mM, and the cultures were incubated overnight at 28°C. Triton X-100-solubilized extracts were prepared as described previously (31) . To sporulation and ascus formation ( Fig. 2A) . Carbohydrate accumulation is a hallmark of the sporulation process and can be detected by staining with iodine vapor (32) . Since S. pombe rasl regulates conjugation and sporulation, cells with a defect in the rasl pathway will not stain with iodine. Cells containing a hyperactivated rasl are also defective in conjugation and will not stain with iodine (40) . The iodine staining method was therefore used to isolate mutants of S. pombe rasl that can block the conjugation-sporulation process. An expression library for mutants of rasl was generated by PCR as described in Materials and Methods. Of 26,000 colonies established by transformation of wild-type S. pombe with the library, 69 failed to stain positively for starch accumulation by iodine vapor. Of the 69, 45 were determined microscopically to have a pheno-type indistinguishable from that induced by activated rasl mutants. S. pombe cells containing an activated rasl allele exhibit an exaggerated sexual response characterized by heightened agglutination, the formation of elongated conjugation tubes, and a failure to conjugate under starvation conditions (20, 40) . These characteristics are referred to as a hypersexed phenotype. Plasmid DNA was successfully rescued from 21 of the remaining 24 isolates. Of these, 13 were wild type on retransformation and 8 dominantly interfered with conjugation or sporulation. These eight interfering mutants were equally distributed into two phenotypically distinct categories. The first type of interfering mutants conferred a ste6null phenotype onto wild-type S. pombe cells ( Fig. 2B and E) "Relative to the wild-type frequency. Each + designates an increment of 25%; -/+ indicates less than 1%. For conjugation-defective cells, polyethylene glycol fusion was used to generate diploids for analysis of sporulation efficiencies. " Expressed from the vector pVINCEI. ' Refers to the elongated conjugation tubes seen in strains expressing hyperactivated rasl.
CDC25, and its disruption manifests as a conjugation defect (26) . The second type of interfering mutants conferred a rasJnuil phenotype when transformed into wild-type cells ( Fig.   2C and F). Similar to the first type of interfering mutants, wild-type cells transformed with the second type of mutants were also conjugation defective. However, unlike the first type of mutants, they caused additional defects: cells were rounded rather than elongated, and sporulation of diploid cells was also suppressed. Sequence analysis of the mutant rasi genes revealed that only four of the eight clones had single missense mutations. Each of the ste6null or raslnul category of interfering mutants had two members.
There was a correlation between the positions of the mutations and the interfering phenotypes that they induced (Fig. 2) . The two mutants that conferred a phenotype similar to a ste6 disruption were altered at amino acid 22, where a serine encoded by AGT was changed into a cysteine (TGT, transversion, SPraslCYs-22) or into an asparagine (AAT, transition, SPraslAsn-22). These are analogous to the Asn-17 mutation of vertebrate H-ras (15) . Those interfering mutants that conferred a phenotype similar to a rasi disruption were altered at amino acid position 62, where an aspartic acid encoded by GAC was changed to a glycine (GGC, transition, SPras161y-62) or to a tyrosine (TAC, transversion, SPraslTYr-62). Others have previously introduced mutations into the analogous Asp-57 of H-ras, but interfering mutants were not created thereby (14, 28) .
Genetic analysis of the S. pombe interfering mutants. We observed that neither the SPraslCYs-22 nor the SPraslTYr-62 mutant blocked the hypersexed phenotype associated with an activated raslva,l7 (Table 3) , thereby indicating that they both interfere upstream of rasi. Position 22 of S. pombe rasl corresponds to position 17 of vertebrate H-ras. Mutations at position 17 of vertebrate H-ras have been shown to dominantly interfere with RAS function in vertebrates (14, 15) . A similar mutation at nearby position 15 of H-ras, or the analogous position 22 of S. cerevisiae RAS2, also creates a dominant interfering mutant that likely functions by sequestration of the RAS-GEF in S. cerevisiae encoded by CDC25 (38, 48) . In S. pombe, the interfering property of SPraslCys-22 is indistinguish-able from that observed for RAS2Ala-22 (Table 4 ). We therefore predicted that the SPraslCYss22 mutant might interfere with Rasl by similarly sequestering the S. pombe homolog of the CDC25 gene product encoded by ste6. Indeed, overexpression of ste6 in a wild-type strain containing either the dominant interfering SPraslCys-22 or RAS2Ala-22 mutant suppressed the conjugation defect (Table 4 ). The conjugation defect can also be overcomed by overexpression of ras] or the kinase that functions downstream of rasi, byri (39), or byr2 (59) . Our genetic data therefore suggest that mutants represented by positions 15 and 17 of H-ras have as their common target the CDC25 class of regulatory exchange factors.
In contrast to SPraslCYs22, which blocked only conjugation, the SPraslTYr-62 interfering mutant blocked conjugation and sporulation and interfered with cellular morphology. Overexpression of the protein kinase encoded by byri or byr2 in a are high-copy-number plasmids for expressing genes from an adh promoter (see Table 2 ).
SPraslTYr-62-containing strain was only able to suppress the sporulation defect, whereas overexpression of wild-type rasl was able to overcome all SPraslTYr-62_induced defects ( Table  4 ). This suppression profile is indistinguishable from that observed for a strain with rasl deleted (39, 59) . The ability of the SPraslTYr-62 mutant to block Rasl function more profoundly than the SPraslPys-22 mutant suggests that Rasl is regulated by other activators besides that encoded by ste6. ral2 has been proposed to encode an alternate positive regulator of rasl, since it functions upstream of rasl and its disruption is phenotypically indistinguishable from a rasl disruption (22) . We observed that ral2 overexpression did not rescue interference by SPraslCys-22 or SPraslTYr-62 (Table 4 ). Genetic analysis of S. cerevisiae R4S2TY'-64. In S. cerevisiae, products of RAS genes are involved in cell growth and regulation of cellular responses to nutrient signals. They are regulated in a positive fashion by the gene product of CDC25 (6, 8) , encoding its GEF, and negatively by products of IRA] and IRA2, encoding homologs of mammalian GTPase-activating proteins (55) . S. cerevisiae cells containing a hyperactivated RAS exhibit a characteristic heat shock sensitivity (47) . A mutant analogous to SPraslTYr-62, RAS2Tyr-64 was made from RAS2 of S. cerevisiae to determine if it too has interfering properties. We found that RAS2Tyr-64 inhibits growth of S. cerevisiae cells and that this inhibition can be relieved by overexpression of elements in the RAS-adenylyl cyclase pathway. RAS2TYr-64 did not inhibit the growth of a strain containing an activated RAS2Va-19 allele, therefore showing that RAS2TYr-64, like SPraslTYr-62 in S. pombe, functions upstream of RAS (data not shown). As further indication that the interference is upstream of RAS, RAS2TY`cannot attenuate the heat shock sensitivity of a RAS2Vall9-containing strain ( Fig. 3 ; Table 5 ).
We next tested if RAS2TYr-64 can attenuate the heat shock sensitivity resulting from RAS that is hyperactivated by disruption of the negative regulators encoded by IRAI and IRA2. RAS2TYr-64 was able to attenuate the heat shock sensitivity of strains deleted of either or both IRAI and IRA2 ( Fig. 3 ; Table  5 ). An iralnull ira2fnull strain is still heat shock sensitive when the positive regulator CDC25 is also deleted (1). RAS2TYr-6 was capable of reversing the heat shock phenotype even in a cdc25null iral null ira2nuIl strain (Table 5 ). In contrast, we found that the interfering mutant RAS2Ala-22 can attenuate the heat shock phenotype of an iralnull ira2null strain but not a cdc25null iralnuln ira2null strain. We take this to mean that a positive a +, attenuation of the heat shock sensitivity relative to the same strain containing a control plasmid; -, absence of effect on heat shock sensitivity. The vector used in the control and for expression of the interfering RAS mutants, resulted in no suppression of heat shock sensitivity. b Heat shock assays were carried out at 55°C (iralnulI and ira2nuIl) or at 52°C (iralnull ira2null, cdc25null iralnuIl ira2null, and RAS2Val-s9, because of the increased heat shock sensitivity of the strains).
regulator of RAS2 other than CDC25 exists in S. cerevisiae and is also the target of RAS2TYr-I.
Interfering properties of mammalian H-ras rS7. A mutation analogous to SPraslTYr-62 was made in H-ras at position 57, H-rasTyr57, and expressed in wild-type S. pombe or S. cerevisiae cells. The interference resulting from SPraslTYr-62 was mimicked by H-rasTYr-57 when expressed in S. pombe (Table 3 ). However, in S. cerevisiae, it interfered more weakly, failing to suppress the heat shock phenotype of strains deleted of both IRAI and IRA2 (Table 5 ).
We also studied two double mutants of H-ras in S. pombe. To test if the interfering mutant was functioning via titration of upstream regulators rather than downstream effectors, we constructed a double mutant that contains both a Tyr-57 mutation and an effector loop mutation, Ala-35, that is believed to block downstream signaling from ras (52) . This double mutant, H-rasAIa-35, Tyr-57, still induced a raslnuII phenotype, indicating that the dominant interference is not due to blocking downstream elements of the rasl pathway ( Table 3) .
The H-rasla-35 mutant did not exhibit any interfering functions, which is consistent with observations by others that Thr-35 substitutions of H-ras block its own function without interfering with endogenous H-ras functions (14, 28) . We also tested if membrane localization is required for the dominant interfering properties of H-rasTyr 7. It was previously shown that blocking the posttranslational addition of lipid to Cys-186 of the CAAX motif (63) for the interfering mutant H-rasAsnl7 abolished its interfering properties (15) . Mutation of Cys-186 to an arginine in H-ras r-57 also blocked its interfering activities when tested in S. pombe. H-rasTyr-s7, Arg-186 failed to inhibit sexual development or effect the cellular morphology of wild-type S. pombe cells (Table 3) .
Two-hybrid analyses of interactions between H-ras proteins and its effectors. The two-hybrid system (18) has been used to study proteins that interact with H-ras (57, 58) . The S. cerevisiae reporter strain L40 permits the detection of proteinprotein interaction by transcriptional activation of both a HIS3 and a lacZ gene. As reported previously (58) , both H-ras'W and activated H-rasval2 interacted with the catalytic domain of S. cerevisiae exchange factor CDC25, indicated by complementation of host histidine auxotrophy and by a ,B-galactosidase color assay (Fig. 4) . They also interacted with two downstream effectors of RAS, budding yeast adenylyl cyclase and mammalian RAF (Fig. 4) . In contrast, both the H-rasMals5 and H-rasTYr-57 interfering mutants failed to interact with the downstream effectors. Relative to H-ras'W, the H-rasAaI1s and H-rasTyr-57 mutants interacted more strongly with CDC25, as indicated by the increased intensity from the ,-galactosidase VOL. 14, 1994 on (Fig. 4 ). This finding confirms our genetic data suggesting that the interfering mutants function through sequestration of upstream activators of RAS.
Guanine nucleotide binding characteristics of H-rasTyr57. Previously characterized dominant interfering mutants of RAS have been shown to have altered affinities for guanine nucleotides, exhibiting a preference for binding GDP over GTP (14, 28, 45) . We therefore determined if this was a property shared by the H-rasT'yr-57 mutant. H-raswT and H-rasTyr-57 were purified as fusion proteins, and their nucleotide binding properties were determined by using a relative affinity assay as described by Farnsworth and Feig (14) (Fig. 5 ). Whereas H-ras'W bound GDP and GTP with similar affinities, the H-rasTYr-57 mutant exhibited less than a 10-fold preference for GDP in the presence of GTP. Therefore, H-rasTYr-57, similar to other interfering mutants, binds preferably to GDP over GTP.
Interaction of H-ras proteins with the catalytic domain of the human cdc25GEF. We next determined if there were biochemical differences between the interactions of wild-type or interfering mutant H-ras proteins and a human homolog of S. cerevisiae CDC25, cdc25GF. A GST fusion with the catalytic domain of cdc25GEF was constructed as described in Materials and Methods. Wild-type or mutant H-ras protein, in the nucleotide-free state, readily associates with GST-cdc25GEF bound to glutathione agarose (Fig. 6, lane 1) , confirming previous observations by Lai et al. (31) . The H-ras'W protein could be readily released from the glutathione agarose-GST-cdc25GEF complex by addition of 10 mM GTP or GDP (Fig. 6) . The H-raSAsn1 mutant could be only partially released from the agarose matrix by addition of 10 mM GTP or GDP.
However, in marked contrast to H-ras'W and H-rasAn17 proteins, 10 mM GTP or GDP allowed only a trace release of H-rasTyr-57 protein (Fig. 6, lanes 2 and 3, respectively) . Following elution of the H-ras proteins by GTP or GDP from the complexes, we treated each of the resulting complexes with 5 mM glutathione to determine the amounts of the various H-ras proteins remaining bound to GST-cdc25GEF. Western blot 1 Binding of guanine nucleotides to preformed complexes of H-ras proteins and the catalytic domain of human cdc25GEF. GDP and GTP are unable to effectively disrupt a complex of nucleotide-free H-rasTYr-57 and GST-cdc25GEF under conditions in which H-ras'W is readily dissociated from GST-cdc25GEF. This observation indicates that either the H-rasTYr-57 mutant, when complexed with GST-cdc25GEF, has a very low affinity for guanine nucleotides and hence remains in a nucleotide-free state tightly complexed with GST-cdc25GEF or that the binding of guanine nucleotides to the H-rasTYr-57 . GST-cdc25GEF complex does not induce the conformational changes in H-rasTYr-57 necessary for its release from GST-cdc25GEF. We therefore examined the ability of complexes of GST-cdc25GEF and either H-ras"', H-rasAsnl7, or H-rasTyr-57 protein to bind 3H-labeled guanine nucleotides at a concentration of 1 p.M. Previous work has shown that a GDP or GTP concentration of 1 p,M is above that required for saturation of binding of the H-ras * GST-CDC25GE complex (37) . At this concentration of guanine nucleotides, H-ras r protein is released to near completion (data not shown; see reference 37), whereas mutant H-ras proteins remain bound to GST-cdc25GEF. Therefore, we determined the total guanine nucleotide bound to H-ras proteins both complexed to and dissociated from GST-cdc259EF* There was no significant change in the ability of H-ras'r, H-rasAsn-17, or H-rasTYr-57 protein, as a preformed complex with GST-cdc25GEF, to bind guanine nucleotides ( Table 6 ). Thus, in this assay, H-rasln-l7 or H-rasTYr-57 protein complexed to GST-cdc25GEF does not have any apparent defect in the ability to bind guanine nucleotides. Rather, the binding of guanine nucleotides to these complexes does not allow the H-rasln-l7 or H-rasTYr-57 protein to dissociate from cdc25GEF.
DISCUSSION
Dominant interfering mutants of rasl that block rasl functions when expressed in wild-type S. pombe cells have been isolated. These mutants fall into two categories. Type I confers a ste6null phenotype. Type II confers a raslnul phenotype. Type I mutants, analogous to the previously described H-rasAlal5 (48) and H-rasMal17 mutants (15) , likely function by titrating out some positive regulators of RAS, e.g., the nucleotide exchange factors encoded by the S. pombe ste6 gene and the S. cerevisiae CDC25 gene. Evidence for this comes from our observation that the interfering phenotypes induced by the SPraslQlys22 mutant or the RAS2Ma-22 mutant can be completely reversed by overexpression of ste6. In a two-hybrid protein-protein interaction experiment, the type I human H-rasAla 15 mutant binds the yeast S. cerevisiae exchange factor, CDC25, more strongly than H-ras"'. We also demonstrate that the H-rasni'7 protein binds more stably to the catalytic domain of human cdc25 gene product, cdc25GEF, at concentrations of guanine nucleotides that will effectively dissociate H-ras'W from a similar complex.
The type II mutants, like the type I mutants, also function upstream of RAS and not by titrating out downstream effectors of RAS. First, SPraslTYr,62 did not diminish the hypersexed phenotype of S. pombe cells containing activated Raslval'l7, and RAS2TYr-64 did not block the heat shock phenotype in S. cerevisiae cells containing activated RAS2Vall9. These observations also indicate that it is unlikely that these mutants interfere with RAS processing, as the mechanism for interference. Second, we also constructed a double mutant, H-ras , containing an Ala-35 mutation that reduces biological activity of H-ras by disrupting interaction with the immediate downstream target (52) . The double mutant maintained its ability to block rasl function. Third, in a two-hybrid study, it was found that the H-rasTYr-57 mutant was not able to interact with two downstream effectors, adenylyl cyclase and RAF, but bound CDC25 more strongly. Both the doublemutant experiment and the results from the two-hybrid system support the conclusion that the H-rasTyr-57 mutant is interfering by titrating out upstream activators of RAS.
The type II mutants represent a novel class of interfering mutants with properties distinguishing them from the type I mutants. They exhibit an interference more pronounced than that observed for the type I mutants. Type II mutants can inhibit all rasl-associated phenotypes in S. pombe, whereas type I mutants, similar to a ste6 disruption, can block conjugation but cannot interfere with sporulation or cell morphology. The type I interfering mutants can be overcome by overexpression of ste6, suggesting that ste6 is its target. Interference by type II mutants cannot be overcomed by overexpression of ste6. In S. cerevisiae, a type II mutant can attenuate the heat shock sensitivity of an iralnull ira2null or a cdc25null iralnull ira2null strain. In contrast, a type I mutant attenuated the heat shock sensitivity of an iralnull ira2null strain but not a cdc25null iralnull ira2null strain. The type II mutant is also biochemically distinguishable from the type I mutant in a cdc25GEF binding and release assay. We showed that a complex of H-ras'T, in its nucleotide-free state, and cdc25GEF can be readily disrupted in the presence of guanine nucleotides. Under identical conditions, a complex containing H-ras fry57 is more severely impaired in the ability to dissociate from cdc25GEF than is a similar complex containing H-rasAsnl7. The more severe defect in dissociation for type II mutants may explain why it interferes more strongly than type I mutants. The more severe defect, however, does not explain the genetic data indicating that the type II mutants interfere more profoundly with RAS functions than do the type I mutants and that they do so even in the absence of the known GEFs. This suggests that type I and type II interfering mutants have different specificities, with the type II mutants targeting other activators of RAS besides VOL. 14, 1994 on November 13, 2012 by MAIN LIBRARY http://mcb.asm.org/ 3716 JUNG ET AL. those encoded by ste6 in S. pombe and its homolog CDC25 in S. cerevisiae.
The type II mutants have amino acid substitutions at a site previously undescribed for a RAS dominant interfering mutant, namely, that corresponding to position 57 of human H-ras. Asp-57 of H-ras localizes to a DX2G motif that is strictly conserved not only for the RAS superfamily but also for the GTPase superfamily (4) . This indicates a structural and functional conservation of this region in this class of proteins. Ser-17, Thr-35, and Asp-57 of H-ras represent three amino acids critical for Mg2+ interaction (36, 43, 44) . The importance of Mg2+ coordination in H-ras regulation is emphasized by the fact that appropriate alterations of either Ser-17 or Asp-57 can generate dominant interfering mutants. Previous reports have suggested that the deliberate manipulation of position 57 might generate interfering mutants of H-ras. Neither an Ala-57 (28) nor an Asn-57 (14) mutation proved interfering, thus indicating that the generation of interfering mutants at this position is dependent on the amino acid substitution.
The mechanism of interference is not fully understood. It has been shown that the nucleotide-free or GDP-bound form of RAS complexes more tightly to GEFs than the GTP bound form of RAS (31) . Defects in the ability of RAS to bind guanine nucleotides might therefore explain how interfering mutants function. We have shown here that whereas wild-type H-ras binds GDP and GTP with similar affinities, a type II interfering mutant binds guanine nucleotides, but with a preference for GDP over GTP. This is a property shared by type I interfering mutants (14, 15, 28) . Such a bias, however, is insufficient for predicting whether a RAS mutant will be interfering, since an Ala-57 mutation (28) was not interfering although it exhibited a 39-fold bias for GDP over GTP. A defect in nucleotide binding to RAS proteins also cannot account for dominant interference properties, since activated mutants of H-ras that exhibit profound defects in nucleotide binding have been described (16, 30) . From the work presented here, showing that the mutants are impaired in the ability to be dissociated from cdc25GEF by guanine nucleotides, and the work of others (14, 28) , we suggest that a common defect of dominant interfering mutants in RAS proteins may be the inability to adopt a guanine nucleotide-bound conformation necessary for release from cdc25GEF-related molecules.
The discovery of type II interfering mutants opens new opportunities for further investigations. First, the high-affinity interaction between the type II mutants and GEFs might serve as a biochemical tool for purification and characterization of these alternate activators. These other activators of RAS might also be found by screening for suppressors of the type II interfering mutants in either S. cerevisiae or S. pombe. Second, since all G proteins contain the DX2G motif (4) in which the type II mutation is localized, it would be useful to determine if manipulation of this conserved aspartic acid in other G proteins will constitute a general strategy for generating interfering mutants. Third, type I interfering mutants have been used to dissect RAS function in mammalian systems (7, 54) . Since our genetic analyses in two yeast systems indicate that the type I mutants do not completely abolish RAS functions, a conservative interpretation of the effects of type I mutants in mammalian systems is warranted until similar mammalian studies are carried out with type II interfering mutants. The ability of the two forms of RAS mutants to interfere in a discriminatory manner with RAS pathways suggests the interesting possibility that the RAS effector is coupled with the upstream activator with which RAS associates. The presently available repertoire of RAS exchange factors isolated from mammalian cells (9, 10, 24, 34, 51, 61, 65) and the availability of these two forms of interfering RAS mutants should allow us to test this possibility.
